Evening administration of blood pressure-lowering drugs provides no convincing evidence of significant advantage over morning dosing for BP control or reduction of cardiovascular events.
Does evening administration of antihypertensive drugs improve blood pressure control and reduce cardiovascular events compared to morning administration in patients with hypertension?
Current evidence does not support a routine switch to evening administration of antihypertensive medications to improve cardiovascular outcomes, pending results from ongoing trials.
: Blood pressure (BP) follows a circadian rhythm with a physiological decrease during the night. Studies have demonstrated that nocturnal BP as well as its dipping pattern during night-time have a significant prognostic importance for mortality and the occurrence of cardiovascular events. Therefore, hypertension management guidelines recommend to ascertain that patients treated for hypertension have well controlled BP values around the clock. To improve hypertension control during the night and eventually further reduce cardiovascular events, it has been proposed by some to prescribe at least one antihypertensive medication at bedtime. In this review, we have examined the data which could support the benefits of prescribing BP-lowering drugs at bedtime. Our conclusion is that there is no convincing evidence that the administration of BP-lowering drugs in the evening provides any significant advantage in terms of quality of BP control, prevention of target organ damage or reduction of cardiovascular events. Before changing practice for unproven benefits, it would be wise to wait for the results of the ongoing trials that are addressing this issue.
Burnier et al. (Fri,) conducted a review in Hypertension. Evening administration of antihypertensive drugs vs. Morning administration was evaluated on Quality of BP control, prevention of target organ damage, or reduction of cardiovascular events. Evening administration of blood pressure-lowering drugs provides no convincing evidence of significant advantage over morning dosing for BP control or reduction of cardiovascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: